会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明授权
    • Dimeric arylisoquinoline alkaloids and derivatives thereof
    • 二聚芳基异喹啉生物碱及其衍生物
    • US06331630B1
    • 2001-12-18
    • US09527002
    • 2000-03-16
    • Gerhard BringmannMichael R. BoydMatthias Wenzel
    • Gerhard BringmannMichael R. BoydMatthias Wenzel
    • C07D40110
    • C07D491/04A61K31/47C07D217/02C07D217/04C07D217/24
    • The present invention provides new naphthylisoquinoline derivatives. In particular, the present invention furthermore provides novel dimeric arylisoquinoline alkaloids comprised of coupled first and second arylisoquinoline monomers. Monomeric and dimeric compounds of the present invention have medically useful properties, such as antimicrobial properties, more specifically such as antimalarial and antiviral properties. Monomeric compounds of the present invention are also useful as building blocks or intermediates for synthesis of novel dimeric arylisoquinoline alkaloids. Monomeric and dimeric compounds of the present invention may be obtained in substantially pure form by total synthesis, partial synthesis, or derivatization from known synthetic or naturally occurring compounds, and by isolation and purification from plants of the Dioncophyllaceae and Ancistrocladaceae families.
    • 本发明提供新的萘基异喹啉衍生物。 特别地,本发明还提供由偶联的第一和第二芳基异喹啉单体组成的新的二聚芳基异喹啉生物碱。 本发明的单体和二聚体化合物具有医学上有用的性质,例如抗微生物性质,更具体地,例如抗疟疾和抗病毒性质。 本发明的单体化合物也可用作合成新型二聚芳基异喹啉生物碱的结构单元或中间体。 本发明的单体和二聚体化合物可以通过从合成或天然存在的化合物的全部合成,部分合成或衍生化,以及通过从Dioncophyllaceae和Ancistrocladaceae家族的植物中分离和纯化而以基本上纯的形式获得。